2022
DOI: 10.1007/s00296-021-05074-0
|View full text |Cite
|
Sign up to set email alerts
|

Sjögren's syndrome associated with erosive rheumatoid arthritis alters its prognosis and long-term therapeutic response: a case–control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 14 publications
0
5
0
Order By: Relevance
“…It is worth noting that if there are comorbidities, such as rheumatoid arthritis with Sjogren's syndrome or ankylosing spondylitis with osteoporosis, the treatment of these comorbidities is relatively mature, and the disease outcome is good [ 37 , 38 ]. However, interdisciplinary studies on comorbidities are relatively rare, and the prognosis for patients is poor.…”
Section: Discussionmentioning
confidence: 99%
“…It is worth noting that if there are comorbidities, such as rheumatoid arthritis with Sjogren's syndrome or ankylosing spondylitis with osteoporosis, the treatment of these comorbidities is relatively mature, and the disease outcome is good [ 37 , 38 ]. However, interdisciplinary studies on comorbidities are relatively rare, and the prognosis for patients is poor.…”
Section: Discussionmentioning
confidence: 99%
“…With the Sharp/van der Heijde method, Laroche et al demonstrated that the RA/SS group had more radiographic joint damage (n=39, median=15.4) compared with RA alone (n=39, me-dian=13.9). However, there was no statistical significance (p=0.79) (32). Brown et al also described the same tendency; RA/SS (n=85, median=47.5) having more radiographic joint damage than RA alone (n=744, median=17.0) (24).…”
Section: Vasmentioning
confidence: 91%
“…2A). For meta-analysis of DAS28-CRP we included 6 studies (3,24,26,28,32,33) comprising 2166 RA and 330 RA/ SS patients. We adopted a random effects model due to the high heterogeneity between studies (I2=90%, τ2=0.32, p<0.01) (Fig.…”
Section: Composite Measures Of Disease Activitymentioning
confidence: 99%
See 2 more Smart Citations